Trial Profile
Uterine Fibroids: Impact of Ulipristal Acetate 10 mg on ART Results
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 13 Oct 2020 Status changed from completed to discontinued.
- 29 Aug 2016 Status changed from recruiting to completed.
- 23 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.